Ceribell (CBLL) CEO trades 39K shares under 10b5-1 plan
Rhea-AI Filing Summary
Ceribell, Inc. director and CEO Xingjuan Chao exercised stock options and sold shares in a planned trade. On April 6, 2026, she exercised options for 25,000 shares of Common Stock at $4.70 per share and sold 39,000 shares at a weighted average price of $18.40 per share pursuant to a Rule 10b5-1 trading plan. After these transactions, she holds 850,347 shares directly and 369,088 shares indirectly through the ACP 2021 Trust, where she is a co-trustee and disclaims beneficial ownership beyond her pecuniary interest.
Positive
- None.
Negative
- None.
Insights
Ceribell’s CEO executed a planned option exercise-and-sell, retaining a large equity stake.
Ceribell’s President and CEO Xingjuan Chao exercised options for 25,000 shares at $4.70 per share and sold 39,000 shares of Common Stock at a weighted average price of $18.40. All trades were made under a pre-arranged Rule 10b5-1 trading plan, indicating the timing was set in advance.
Following the transactions, she directly holds 850,347 shares and has indirect exposure to 369,088 shares through the ACP 2021 Trust. The sales represent a small portion of her visible holdings, so the filing mainly reflects routine liquidity and compensation usage rather than a major change in ownership stance.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 1,446 | $0.00 | -- |
| Exercise | Stock Option (Right to Buy) | 23,554 | $0.00 | -- |
| Sale | Common Stock | 14,000 | $18.40 | $258K |
| Exercise | Common Stock | 1,446 | $4.70 | $7K |
| Sale | Common Stock | 1,446 | $18.40 | $27K |
| Exercise | Common Stock | 23,554 | $4.70 | $111K |
| Sale | Common Stock | 23,554 | $18.40 | $433K |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.03 to $18.77, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote. The Reporting Person is a co-trustee of the ACP 2021 Trust, and therefore may be deemed to share beneficial ownership of these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein. The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of April 1, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. The stock option is fully vested and currently exercisable.